Not applicableStudy completedNCT01916629What this trial is testingPhotocil (Topical) for the Treatment of Psoriasis VulgarisWho this might be right forPsoriasis Applied Biology, Inc. 12
Not applicableStudy completedNCT00236171What this trial is testingEvaluation of Topical Antipsoriatics in the Psoriasis Plaque TestWho this might be right forPsoriasis Vulgaris Technische Universität Dresden 14
Post-approval studies (Phase 4)Study completedNCT04080661What this trial is testingTherapeutic Drug Monitoring of Secukinumab in Psoriasis Patients.Who this might be right forPsoriasis Vulgaris University Hospital, Ghent 82
Not applicableUnknownNCT04242082What this trial is testingGlucose Trnsporter and PEDF in PsoriasisWho this might be right forPsoriasis Vulgaris Assiut University 75
Testing effectiveness (Phase 2)Study completedNCT01936337What this trial is testingTopical Double-blind, Randomized, Placebo-controlled Study in Psoriasis PatientsWho this might be right forPsoriasis Vulgaris Delenex Therapeutics AG 59
Testing effectiveness (Phase 2)Study completedNCT00875277What this trial is testingA Psoriasis Plaque Test With LEO 29102 Cream and Its Combination ProductsWho this might be right forPsoriasis Vulgaris LEO Pharma 24
Post-approval studies (Phase 4)Study completedNCT02125279What this trial is testingLong Term Safety and Efficacy Study of Calcitriol 3 mcg/g Ointment in Pediatric Subjects With Plaque PsoriasisWho this might be right forPsoriasis Vulgaris Galderma R&D 54
Not applicableStudy completedNCT04989296What this trial is testingInformative Value of Determining the Level of NF-κB Translocation in Lymphocyte Populations in Children With PsoriasisWho this might be right forPsoriasis Vulgaris National Medical Research Center for Children's Health, Russian Federation 120
Post-approval studies (Phase 4)Study completedNCT06042647What this trial is testingAnti-Inflammatory Effects of 0.045% Tazarotene/0.01% Halobetasol Lotion in PsoriasisWho this might be right forPsoriasis Vulgaris Dermatology Consulting Services, PLLC 10
Testing effectiveness (Phase 2)Looking for participantsNCT05815797What this trial is testingShuiniujiao Dihuang Decoction With Variation for the Treatment of PsoriasisWho this might be right forPsoriasis Vulgaris Chinese University of Hong Kong 58
Early research (Phase 1)Study completedNCT00277225What this trial is testingAssess the Pharmacokinetics, Immunogenicity and Safety of Escalating Doses of BMS-188667 Given as a Single Intravenous Infusion to Patients With Psoriasis VulgarisWho this might be right forPsoriasis Vulgaris Bristol-Myers Squibb 32
Testing effectiveness (Phase 2)Study completedNCT02416258What this trial is testingA Psoriasis Plaque Test Trial With LP0113 Spray in Patients With Psoriasis Vulgaris (LP0113-1123)Who this might be right forSkin and Connective Tissue Diseases LEO Pharma 50
Early research (Phase 1)Not Yet RecruitingNCT07802964What this trial is testingA Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Pharmacodynamics of HRS-4139 in Healthy ParticipantsWho this might be right forPsoriasis Vulgaris Fujian Shengdi Pharmaceutical Co., Ltd. 40
Testing effectiveness (Phase 2)Study completedNCT00593177What this trial is testingA Safety and Efficacy Study of a Topical Gel for the Treatment of Mild to Moderate PsoriasisWho this might be right forPsoriasis Vulgaris Manhattan Pharmaceuticals 61
Large-scale testing (Phase 3)Study completedNCT01636687What this trial is testingJudging the Efficacy of Secukinumab in Patients With Psoriasis Using AutoiNjector: a Clinical Trial Evaluating Treatment Results (JUNCTURE)Who this might be right forPlaque-type Psoriasis Novartis Pharmaceuticals 182
Testing effectiveness (Phase 2)Study completedNCT01465282What this trial is testingEvaluation of the Efficacy, Safety and Toleration of CT327 Ointment in Patients With Psoriasis VulgarisWho this might be right forPsoriasis Vulgaris Creabilis SA 160
Post-approval studies (Phase 4)Study completedNCT04306315What this trial is testingAdjusted Brodalumab Dose Compared With Standard Brodalumab Dose in Subjects With Moderate-to-severe Plaque Psoriasis and ≥120 kg Body WeightWho this might be right forPsoriasis Vulgaris LEO Pharma 385
Post-approval studies (Phase 4)Looking for participantsNCT05390515What this trial is testingPsoriatic Immune Response to TildrakizumabWho this might be right forPsoriasis Vulgaris University of California, San Francisco 10
Not applicableStudy completedNCT04136314What this trial is testingImpact of Decision-Framing in PsoriasisWho this might be right forPsoriasis VulgarisPsoriatic ArthritisPsoriasis University of Southern California 90
Not applicableStudy completedNCT03284879What this trial is testingPost-Marketing Surveillance Study of OTEZLAWho this might be right forPsoriasis Amgen 1,086